20 (AIDX) Equity Ratio (2024 - 2026)

20 (AIDX) reported Equity Ratio of 0.44 for Q1 2026, up 9566.94% quarter-over-quarter from 0.0 in Q4 2025.

20 (AIDX) Equity Ratio (2024 - 2026) Analysis & Trends

20 has reported Equity Ratio for 3 years, with the latest figure at 0.44 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio changed N/A year-over-year to 0.44; the trailing twelve-month figure through Mar 2026 stood at 0.44 (changed N/A YoY), and the FY2025 full-year result was 0.0, down 101.11% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.44, up from 0.0 in the prior quarter.
  • The five-year high for Equity Ratio was 0.44 in Q1 2026, with the low at 0.0 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.29 across 3 years, with a median of 0.42 in 2024.
  • The largest YoY upside for Equity Ratio was 101.11% in 2025 against a maximum downside of 101.11% in 2025.
  • 20's Equity Ratio stood at 0.42 in 2024, then plunged by 101.11% to 0.0 in 2025, then soared by 9566.94% to 0.44 in 2026.
  • The last three Equity Ratio figures came in at 0.44 (Q1 2026), 0.0 (Q4 2025), and 0.42 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.47
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.50
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.54
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.42
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.29
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.67
10 20 - - 62,884.00 0.44

Historic Data

Download Data
DateValue
Mar 31, 2026 0.44
Dec 31, 2025 0.00
Dec 31, 2024 0.42